RENEWVAX LIMITED
No Analysis Available
Get instant AI-powered insights about this company's financial health, risks, and trends.
Order Analysis - £10- Legal registered address
- Liverpool Science Park 131 Mount Pleasant Liverpool England L3 5TF Copied!
Latest financial results as of 15 October 2025- Cash in bank
- £175.61k
- Current assets
- £205.76k
- Current creditors
- £46.13k
- Shareholders funds
- £689.96k
View full financial accounts- Cash in bank
- £175.61k
- Current assets
- £205.76k
- Current creditors
- £46.13k
- Shareholders funds
- £689.96k
- Company number
- 13878327 Copied!
Accounts
Latest annual accounts were to 31 December 2024
Next annual accounts are due by 30 September 2026
Company financial year end is on 31 December 2025
Confirmation statement
Latest confirmation statement statement dated 27 January 2025
Next statement due by 10 February 2026
Nature of business (SIC)
72110 - Research and experimental development on biotechnology
Previous company names
| Name | Date previous name changed |
|---|---|
| ZAPVAX LIMITED | 15 June 2022 |
Latest company documents
| Date | Description |
|---|---|
| 18/07/2518 July 2025 | Statement of capital following an allotment of shares on 2025-07-18 |
| 02/05/252 May 2025 | Statement of capital following an allotment of shares on 2025-05-02 |
| 28/04/2528 April 2025 | Termination of appointment of Marie O'brien as a director on 2025-03-05 |
| 02/04/252 April 2025 | Total exemption full accounts made up to 2024-12-31 |
| 03/02/253 February 2025 | Confirmation statement made on 2025-01-27 with updates |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company